The Neuro’s drug discovery initiative supports research by developing assays shared with the scientific community
In the past 40 years, the model of drug discovery used by the pharmaceutical industry, while proving successful for some applications, has produced very little for neurodegenerative diseases.
“We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”“Take Parkinson’s disease, for instance: there have been zero new disease modifying medications developed in the last 40 years, despite hundreds of millions of dollars being invested in research,” says Dr. Edward Fon, whose lab focuses on molecular and cellular research into Parkinson’s disease. “We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”
The Neuro’s drug discovery initiative aims to support research by developing assays that investigate different aspects of target cells and sharing these assays with colleagues around the world. The main vehicle for sharing assays is The Neuro’s Induced Pluripotent Stem Cell (iPSC) platform, developed recently with seed money generously donated by Sebastian van Berkom and Ghislaine Saucier.
“We can provide industry-standard assays researchers can use to test compounds,” says Thomas Durcan, another Parkinson’s researcher who manages the iPSC platform. “In collaboration with researchers at Université Laval, we reprogram blood cells from patients with neurological diseases into stem cells, and then transform the stem cells into the type of neural cells most impacted in neuropathology.”
This gives researchers the ability to compare normal and diseased states of the cells within one patient, which has long been possible for some diseases but is a novel advance for neurological research. The Centre for Drug Research and Development, a Canadian nonprofit organization that aims to speed the translation of discoveries into therapies, and the international Structural Genomics Consortium have both formed partnerships with the Tanenbaum Open Science Institute to use the iPSC platform.
“If we can identify potential compounds for targeting diseases such as Parkinson’s and share them so they can be screened and tested throughout the scientific community, we can accelerate the rate of discovery,” says Dr. Fon. “Other researchers can benefit from the resources we develop, and the chances of 100 laboratories finding something useful is much greater than that of one lab working alone. If we can come up with something leading to treatment for Parkinson’s disease, that would be an incredible payback.”
Learn more: Accelerating drug discovery with Open Science
The Latest on: Open Science
[google_news title=”” keyword=”Open Science” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Open Science
- Recent study finds 'garbage lasagnas' forming in open landfills across US release staggering amount of air pollution: 'Decades of trash that's sitting under the landfill'on May 10, 2024 at 10:00 pm
Researchers discovered that over half had sizable methane plumes, which sometimes lasted for months or years. Recent study finds 'garbage lasagnas' forming in open landfills across US release ...
- Go with open mind to Eagle Rock Science Festivalon May 10, 2024 at 5:02 pm
Saturday, May 11, people can spent most of the day learning about science at the second annual Eagle Rock Science Festival. There will be different activities showcasing agricultural science, ...
- Weekend open house can connect your student with a future career in aviationon May 9, 2024 at 1:00 pm
"The airlines industry is desperate for people, whether they're mechanics, or pilots - or if it's people just working in airports," said Kurt Wicklund, Senior Director at the Aerospace & Natural ...
- Open Science: Why you should preprint your next paperon May 7, 2024 at 12:39 pm
What are preprints and how do they benefit you and your research community? Plus find tools that help you keep up with the preprint literature.
- Zooniverse Secures Prestigious Open Science Award from the White Houseon May 2, 2024 at 10:23 am
Read Zooniverse Secures Prestigious Open Science Award from the White House Gallery of Zooniverse project avatars. Credits: ...
- Sara Rouhi joins AIP Publishing as Director of Open Science and Publishing Innovationon April 30, 2024 at 9:51 am
MELVILLE, N.Y., April 30, 2024 /PRNewswire/ -- AIP Publishing (AIPP) announced today that Sara Rouhi has joined the organization in the new role of Director of Open Science and Publishing Innovation.
- The power of open science: Frontiers’ collaborative approach to addressing climate changeon April 17, 2024 at 5:00 pm
The COVID-19 pandemic demonstrated the power of open science to solve a global issue. In the US, the White House, along with a coalition of research organizations, launched the COVID-19 Open ...
- About ESA Open Scienceon May 9, 2023 at 8:10 am
Open science is the idea that the products and the process of science should be freely accessible (i.e. open) to everyone. This includes things like open educational materials, open access ...
- Starting to practice Open Scienceon May 9, 2023 at 8:10 am
Open access (free access without request) publications are an easy way to start practicing open science. There are two type of open access, green and gold. Both are open, and both work to give folks ...
- Our commitment to open scienceon August 10, 2022 at 8:30 am
As a group, these principles form the basis of the open science agenda – an agenda that is currently being defined by stakeholders from around the world. Our goal as a learned society, professional ...
via Bing News